Sorafenib to Treat FLT3-ITD AML
NCT02156297
·
clinicaltrials.gov ↗
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Acute Myeloid Leukemia
FLT3-ITD Mutation
Sponsor
The First Affiliated Hospital of Soochow University